Corteva, Inc.

The seed segment benefits from annual repurchase dynamics, as farmers source Pioneer-branded genetics each planting season, driving consistent volume across FY2021-FY2025. Crop protection sales are more transactional and subject to channel inventory cycles, as demonstrated by the industry-wide destocking in 2023 that pressured results.

Revenue splits roughly 57% seed and 43% crop protection (FY2025), with both segments tied to the same end market of farmer spending and crop economics. Within seed, corn genetics is the largest driver; within crop protection, herbicides represent approximately half of segment sales, with insecticides and fungicides making up most of the remainder.

North America generated approximately 51% of net sales in FY2024, with the U.S. alone likely exceeding 40% of total revenue. Latin America contributed 22% and EMEA 19%, providing meaningful international exposure across four regions but not a balanced regional split.

Corteva's R&D and breeding infrastructure are largely fixed costs that spread across annual planted acres, providing some structural leverage. Operating EBITDA margin held in the 20-22% range across FY2023-FY2025, a level consistent with moderate operating leverage in a physical goods agricultural business that requires substantial seed processing and manufacturing capacity.

Seeds are mission-critical inputs repurchased annually for every growing season, creating repeat-purchase dynamics with meaningful brand loyalty to Pioneer genetics. Crop protection products are more transactional and substitutable, held back in revenue quality by generic competition from Chinese and European manufacturers.